Larimar Therapeutics
LRMR
LRMR
61 hedge funds and large institutions have $114M invested in Larimar Therapeutics in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 8 closing their positions.
Holders
61
Holders Change
+5
Holders Change %
+8.93%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
24
Reduced
13
Closed
8
Calls
$297K
Puts
$189K
Net Calls
+$108K
Net Calls Change
+$44K
Top Buyers
| 1 |
1
Balyasny Asset Management
Chicago,
Illinois
|
$3.44M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$2.35M |
| 3 |
NC
3
Nexthera Capital
New York
|
$2.99M |
| 4 |
AG
4
Artal Group
Luxembourg
|
$8.94M |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$6.44M |
Top Sellers
| 1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$154K |
| 2 |
2
Renaissance Technologies
New York
|
$4.23M |
| 3 |
RA
3
Royce & Associates
New York
|
$3.47M |
| 4 |
SIM
4
Spark Investment Management
New York
|
$786K |
| 5 |
5
D.E. Shaw & Co
New York
|
$2.93M |
